When an aesthetic clinic needs dermal fillers, skin boosters, fat dissolvers, needles, cannulas or everyday consumables, product availability and delivery speed matter almost as much as price.
This is where Aesthetics Warehouse has built its position. The UK-based supplier focuses on professional-use aesthetic products and presents itself as a wholesale supplier for nurses, doctors and aesthetic practitioners.
What Does Aesthetics Warehouse Actually Sell?
Aesthetics Warehouse has built a broad catalogue rather than focusing on only one type of injectable.
Its website currently lists 458 products, covering dermal fillers, skin boosters, fat-dissolving products, needles, cannulas and clinic consumables. The company also highlights regulated CE products and professional-use purchasing.
The product range includes brands and products such as Revolax, Lumifil, EPTQ, Profhilo and Revs Pro. Its best-selling listings include products such as ELASTY Fine Syringes, AIOR 50, Nuvene Flex, AMI NAD+, Juvelook and Aqualyx.
This broad product mix is important because clinics usually need several categories from the same supplier. A supplier that can provide both higher-value injectables and routine consumables has more opportunities to generate repeat orders.
Our experts help businesses identify opportunities, reduce risks, and help you to make smarter decisions. Download insights and data your business require: https://www.towardshealthcare.com/download-sample/5013
Aesthetics Warehouse: Key Business Indicators
| Indicator | Reported figure |
|---|---|
| Customers | 20,264 |
| Orders | 25,349 |
| Products/SKUs listed | 458 |
| Free delivery threshold | £100 |
| Same-day order cut-off | 3 PM |
| Delivery promise | Next working day |
| First-order promotion | 10% off |
| Customer support | 24/7 online support |
These figures are displayed by Aesthetics Warehouse on its website, so they should be viewed as company-reported operating indicators rather than audited financial results.
Sales and Revenue: What Can We Actually Verify?
One important limitation is that Aesthetics Warehouse does not publicly disclose audited annual revenue or profit figures on its website.
That means it would be misleading to assign a specific sales or revenue figure to the company without a verified filing. Its 20,264 customers and 25,349 orders do, however, show meaningful online commercial activity.
The company’s business model also appears focused on repeat professional purchasing. It promotes bulk discounts, competitive wholesale pricing and regular ordering, while its FAQ states that it price-matches products online on a weekly basis.
For comparison, publicly reported figures from larger companies show how much bigger the wider aesthetics supply ecosystem can become.
Galderma, one of the world’s major aesthetics companies, generated $4.41 billion in total 2024 sales. Its Injectable Aesthetics business alone generated $2.299 billion, up 9.6% at constant currency. Neuromodulators generated $1.285 billion, while fillers and biostimulators generated $1.014 billion.
Another useful comparison is India’s Aakaar Medical Technologies. The company reported FY2024–25 revenue of ₹61.58 crore, compared with ₹46.11 crore in FY2023–24 and ₹32.78 crore in FY2022–23. Its own-brand revenue increased to ₹23.11 crore in FY2024–25 from ₹13.94 crore the previous year.
These companies operate at very different scales, but the comparison highlights the commercial opportunity around professional aesthetic products, devices and consumables.
Why Product Breadth and Delivery Matter
Aesthetics clinics operate around scheduled appointments, so supply delays can directly affect clinic operations.
Aesthetics Warehouse attempts to address this through a 3 PM order cut-off for next-working-day delivery, free shipping above £100 and delivery-protection options.
Its professional-only approach is another important part of the business model. The company states that dermal fillers and related products are intended for trained, qualified and insured practitioners rather than general consumers.
This creates a more focused customer base: aesthetic nurses, doctors, clinic owners and other qualified practitioners who may reorder products regularly.
How Does It Compare With Larger Players?
Aesthetics Warehouse is much smaller than global manufacturers such as Galderma, but its role is different.
Galderma develops and manufactures major brands such as Restylane, Sculptra and Dysport, whereas Aesthetics Warehouse primarily operates as a distributor and online supplier, bringing multiple brands and consumables together for professional buyers.
Aakaar provides another interesting comparison because it combines aesthetic products with devices and device consumables. In FY2024–25, Aakaar sold 532,824 units of aesthetic products and 8,930 units of aesthetic devices and device consumables.
For Aesthetics Warehouse, the competitive advantage therefore appears less about manufacturing proprietary products and more about catalogue breadth, pricing, availability, convenience and repeat purchasing.
Company Comparison
| Company | Latest reported sales/revenue | Key strength |
| Aesthetics Warehouse | Not publicly disclosed | Online aesthetic supplies |
| Galderma | $4.41B FY2024 | Injectables, skincare, dermatology |
| Aakaar Medical Technologies | ₹61.58 Cr FY2025 | Aesthetic products & devices |
Overall Evaluation
Aesthetics Warehouse has built a recognizable professional-supply model with 458 listed products, more than 20,000 reported customers and over 25,000 reported orders. Its strongest points are product variety, wholesale positioning, online ordering and fast delivery.
The main limitation when evaluating its financial strength is the lack of publicly disclosed audited sales and profit data. Therefore, customer and order numbers provide better evidence of its operating scale than an estimated revenue figure.
Overall, Aesthetics Warehouse looks strongest as a specialized UK B2B distributor for aesthetic clinics, while companies such as Galderma and Aakaar demonstrate the much larger commercial scale possible across injectable aesthetics, devices, skincare and professional supplies.
Important Links
Get a dashboard built around your niche; with the exact data and insights you need. Request for a demo
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
Connect with us for more enquiry at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium